Results 251 to 260 of about 146,499 (323)

Therapeutic Strategies to Overcome Payload Resistance of Trastuzumab Deruxtecan in HER2‐Positive Cancers

open access: yesCancer Science, Volume 117, Issue 4, Page 996-1009, April 2026.
Overexpression of ABC transporters, especially ABCG2 and ABCB1, mediates acquired resistance to T‐DXd in HER2‐positive cancers. Inhibition of these transporters restored T‐DXd efficacy, highlighting efflux‐mediated resistance as a potential therapeutic target. ABSTRACT Antibody–drug conjugates (ADCs) are emerging as a promising class of targeted cancer
Yuya Murase   +23 more
wiley   +1 more source

Analytical Validation of an Annotation Tool for WGS‐Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology

open access: yesClinical and Translational Science, Volume 19, Issue 4, April 2026.
Selection and validation of a whole genome sequencing pharmacogenomics annotation tool. ABSTRACT Whole genome sequencing (WGS) is increasingly accessible in clinical practice, enabling pharmacogenomics (PGx) integration, including in pediatric oncology.
Meta H. M. Diekstra   +9 more
wiley   +1 more source

Disproportionality Analysis of Fluoroquinolone‐Associated Peripheral Neuropathy in the FAERS Database (2007–2024)

open access: yesClinical and Translational Science, Volume 19, Issue 4, April 2026.
ABSTRACT Fluoroquinolones (FQs) are among the most frequently prescribed antibiotic classes worldwide. Despite their therapeutic versatility in treating bacterial infections, regulatory authorities recognized risks of persistent and potentially irreversible adverse effects, particularly peripheral neuropathy (PN).
Nimra Shamim   +5 more
wiley   +1 more source

Phytochemical Profiling and Computational Docking Studies Revealing the Potential Anticancer and Antioxidant Properties of <i>Heliotropium indicum</i> L. [PDF]

open access: yesScientifica (Cairo)
Shoily SA   +9 more
europepmc   +1 more source

Immune cells composition in the skin and subcutaneous adipose tissue of patients with systemic sclerosis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 482-492, April 2026.
Summary Background and objectives Systemic sclerosis (SSc) is a rare, chronic autoimmune disease characterized by fibrosis of the skin and/or internal organs. Emerging evidence suggests that subcutaneous adipose tissue may contribute to systemic inflammation and fibrosis in SSc.
Marija Geroldinger‐Simić   +3 more
wiley   +1 more source

Zusammensetzung der Immunzellen in der Haut und dem subkutanen Fettgewebe von Patienten mit systemischer Sklerose

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 482-493, April 2026.
Zusammenfassung Hintergrund und Ziele Systemische Sklerose (SSc) ist eine seltene, chronische Autoimmunerkrankung, die durch Fibrose der Haut und/oder der inneren Organe gekennzeichnet ist. Neue Erkenntnisse deuten darauf hin, dass subkutanes Fettgewebe zur systemischen Entzündung und Fibrose bei SSc beitragen kann.
Marija Geroldinger‐Simić   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy